All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit Know AML.
The aml Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the aml Hub cannot guarantee the accuracy of translated content. The aml and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The AML Hub is an independent medical education platform, sponsored by Astellas, Daiichi Sankyo, Johnson & Johnson, Kura Oncology and Syndax, and has been supported through educational grants from Bristol Myers Squibb and the Hippocrate Conference Institute, an association of the Servier Group. The funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View AML content recommended for you
The expression of P-glycoprotein in leukemia cells is associated with the upregulated expression of nestin, a class 6 filament protein
Coculova M, et al., analyzed whether there was a correlation between the expression of P-glycoprotein and the expression of nestin in Acute Myeloid Leukemia (AML) cell lines (SKM-1 and MOLM-13). The study is of interest as the findings could further elucidate the mechanisms by which Multidrug Resistance (MDR) occurs during chemotherapy treatment. The data were published in Leukemia Research in July 2016.
The key findings were:
- Co-expression of P-glycoprotein and nestin in AML cell lines was detected
- Silencing the P-glycoprotein induced the downregulation of nestin
- Nestin expression in L1210 cells transfected with P-glycoprotein gene was observed
In conclusion, a causal relationship was observed between expression of P-glycoprotein and the expression of nestin in AML cell lines. This data suggests that the targeting of the P-glycoprotein could provide a mode of preventing multiple drug resistance to chemotherapy agents used to treat leukemia.
The expression of P-glycoprotein in leukemia cells is associated with the upregulated expression of nestin, a class 6 filament protein.
References